Objective To determine health-related quality of life (HRQoL) and neurocognitive impairment in survivors of pediatric acute liver failure (PALF).
function, including cognitive fatigue. Cognitive fatigue has been operationally defined as a "decline in alerting, orienting, and executive attention performance" as distinct from general fatigue (eg, feeling tired). 6 Health-related quality of life (HRQoL) in these survivors may also be lower than expected compared with healthy children. Detailed assessment of neurocognitive function, cognitive fatigue, and HRQoL is critical to understanding the full impact of PALF.
A prior cross-sectional study of neurocognitive and HRQoL outcomes in PALF survivors with varied etiology was conducted by the Pediatric Acute Liver Failure Study Group (PALFSG). Thirty-six patients aged 6-16 years were assessed 1-6 years after presentation. This study demonstrated average IQ, but greater than expected impairments in motor skills, attention, executive functioning, HRQoL and cognitive fatigue in long-term survivors. 7 The goal of the present longitudinal prospective study, also conducted by the PALFSG, was to characterize more fully in PALF survivors during the first year following presentation and to validate findings from our cross-sectional study. We hypothesized HRQoL and cognitive fatigue would be lower at 6 and 12 months after PALF presentation compared with a matched healthy sample, but would improve from 6 to 12 months. We also hypothesized neurocognitive function (specifically motor, attention, and executive functioning) would be lower compared with test norms at 12 months after PALF.
Methods
PALFSG inclusion criteria are age birth to <18 years, biochemical evidence of acute liver injury without chronic liver disease, and coagulopathy not corrected by parenteral vitamin K or other intervention. Registry participants must have liver synthetic failure with international normalized ratio ≥1.5 associated with HE, or international normalized ratio ≥2.0 with or without HE.
Eligible patients for the present longitudinal study were drawn from the PALFSG (N = 158) and recruited at 12 medical centers in the US and Canada between May 2012 and December 2014, with 1-year follow-up testing through December 2015. None of the patients in the current sample participated in the previously published cross-sectional study. 7 Specific eligibility criteria differed slightly for HRQoL and neurocognitive/ executive functioning testing because primarily of the measures used. Therefore, the samples overlap, but are not the same. The Figure ( available at www.jpeds.com) details the recruitment algorithm and the reasons for nonparticipation.
HRQoL and Fatigue
Eligible patients from 2 to 19 years of age enrolled in the PALFSG completed age-appropriate HRQoL and cognitive fatigue surveys at 6 months (N = 52; 81% of eligible) and 12 months (N = 48; 84% of eligible) following PALF presentation. Subject and parent/ guardian were fluent in English or Spanish.
The healthy sample was derived from 2 previously completed studies 8, 9 and randomly matched by age, sex, and race/ ethnicity to the PALF sample separately for child self-report and parent-proxy report given age differences between the 2.
Executive Function and Neurocognitive Function
Surveys assessing executive functioning were completed by parents of eligible patients age 2-16 years at 6 months (N = 31; 89% of eligible) and 12 months (N = 25; 89% of eligible) after PALF presentation. Eligible patients age 3-16 years completed neurocognitive testing 12 months after PALF presentation (N = 25; 89% of eligible). In addition, participants (≥8 years old) and parents completed the depression and posttraumatic stress disorder (PTSD) surveys along with the neurocognitive testing battery. Eligibility for the present study was assessed at the PALFSG visit. Therefore, if the visit was missed, eligibility could not be determined. Participants and parent/guardian were fluent in English. Exclusions included unstable medical status at time of testing (eg, hospitalizations within 4 weeks prior to testing, awaiting liver transplantation, uncontrolled seizures) or medical factors that could independently affect functioning or invalidate testing (ie, cancer diagnosis; weakness or abnormality of muscle tone or coordination, sufficiently severe that it impaired the ability to perform the physical tasks required for testing; no intelligible speech and/or inability to follow simple commands.) Fourteen children met exclusion criteria at the 12 months visit: non-English speaking (n = 5), hospitalized or listed for liver transplantation (n = 5), impaired speech or muscle weakness (n = 3), and previous cancer diagnosis (n = 1).
Study Design
Participants meeting inclusion criteria were identified by the Data Coordinating Center, which provided weekly reports to site coordinators and investigators of those patients who were due for their 6-and 12-month follow-up visits. The report served as a notice for coordinators to begin scheduling the patient for an in-person follow-up visit with the appropriate amount of time and resources for the visit specific measures to be completed. The 12-month neurocognitive tests were performed or supervised by licensed psychologists.
Written, informed consent was obtained from the child's parent/legal guardian before participation in the PALFSG. Assent was obtained from children as required by individual institutions. The study protocol was approved by the institutional review boards at all PALFSG sites.
Instruments
HRQoL and Fatigue (Completed at 6-and 12-Month Visit). The child self-report (only for ≥5 years old) and parent proxy-report versions of the 23-item Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL, Mapi Research Institute, Lyon, France) 8 and the PedsQL Multidimensional Fatigue Scale (MFS) 10, 11 were administered at both the 6-and 12-month follow-up visits. Items are reverse-scored and linearly transformed to a 0-100 scale, so that higher scores indicate better HRQoL. The PedsQL encompasses (1) Executive Function (Completed at 6-and 12-Month Visit). Parents of children 2 years and older completed age appropriate versions of BRIEF at the 6-and 12-month visit. 13 The BRIEF is a survey of symptoms related to attention and executive functioning that yields composite scores including the Global Executive Composite, the Metacognition Index, and the Behavioral Regulation Index. This scale offers the opportunity to quantify observations of naturalistic behaviors related to executive functioning that are difficult to assess in a formal testing situation. The BRIEF-Preschool Version is designed for use with age 2-5 years and yields a Global Executive Composite, as well as 3 broad indices: Inhibitory Self Control, Flexibility, and Emergent Metacognition.
14 Participants ages 11 years and older also completed the BRIEF-Self Report. . 16 The WPPSI-IV provides index scores in the following areas: Full Scale IQ, Verbal Comprehension, Visual Spatial, and Working Memory, for children age 2-3 years. Additional composites for age 4-7 years include Fluid Reasoning, Processing Speed, and Cognitive Proficiency. The WPPSI-IV is a psychometrically sound measure with reliability estimates ranging from 0.91 to 0.96 for all composite scores except Visual Spatial Index (0.89) and Processing Speed Index (0.86).
The Wechsler Intelligence Scales for Children, Fourth Edition (WISC-IV) 17 was administered to participants aged 6 years through 16 years 11 months 30 days. It is comprised of 4 primary indices similar in content to the WPPSI-V: Full Scale IQ, Verbal Comprehension, Perceptual Reasoning, Working Memory, and Processing Speed. The WISC-IV is also psychometrically strong, with reliability estimates ranging from 0.88 to 0.97 for composite scales. WPPSI-IV and WISC-IV Full Scale IQ, Verbal Comprehension, Visual Spatial/Perceptual Reasoning, and Fluid Reasoning/Perceptual Reasoning Indices are highly correlated (corrected r = 0.84, 0.73, 0.75, 0.77, respectively), with more moderate correlations for Working Memory (corrected r = 0.55) and Processing Speed (corrected r = 0.60).
Adaptive Skills. Parents of children 3 years and older completed the Adaptive Behavior Assessment System-Second Edition (ABAS-II). 18 Adaptive skills, also referred to as "independent living skills," are life tasks that can be completed with increasing degrees of independence as the child develops. On the ABAS-II, adaptive skills are assessed across several areas including communication, community functioning, social skills, self-care, and home living skills.
Visual Spatial and Visual Motor Ability. Participants ages 3 years and older also completed the Beery-Buktenica Developmental test of Visual-Motor Integration, Sixth Edition (VMI-6). 19 The VMI-6 is a measure that uses abstract designs to assess visual perception (matching), motor skills (tracing emphasizing speed and precision), and visual-motor integration (copying).
Attention. Participants ages 4 years and older completed age appropriate versions of the Conners' Continuous Performance Test II (CPT-II), 20 a computerized test of sustained attention that involves responding to targets (all letters except "x") by pressing the space bar as quickly as possible and inhibiting responses to infrequent distracters ("x"). Various aspects of performance are recorded including reaction time speed, variability and SE, number of omissions (missed targets), and commissions (erroneous responses to distracters). The Conners' Kiddie Continuous Performance Test (K-CPT) 21 is based on the CPT-II and yields the same scores, but is designed for children age 4-5 years and requires recognition of pictures rather than letters.
Depression and PTSD (Completed at 12-Month Visit). The
Children's Depression Inventory, Second Edition (CDI-2), 22 a standardized survey assessing symptoms of depression, was completed by parents and children who were at least 8 years of age. Simply worded, multiple-choice questions asked respondents to rate the presence/severity of various indicators of depressed mood (eg, difficulties with sleep, appetite, feelings of sadness). CDI-2 Parent and self-report yield a total score and 2 scale scores (Emotional Problems and Functional Problems).
Participants 8 years of age and older and their parents completed the Abbreviated UCLA PTSD-Reaction Index. 23 This is a 9-item instrument that can help screen for PTSD after any type of trauma exposure. The abbreviated version has good convergent validity and excellent sensitivity (0.93) and specificity (0.87) for detecting PTSD diagnosis. Children should be considered to have clinically significant PTSD symptoms with a score of 10 or higher and subsequently, offered a mental healthcare referral.
Statistical Analyses
Descriptive statistics were generated for demographic and clinical patient variables and are reported as medians and 25th and 75th quartiles for continuous variables and frequencies/ proportions for categorical variables.
To assess whether participants had worse HRQoL and symptoms of fatigue than average, independent-samples t tests were used to compare our sample with a matched sample of healthy May 2018
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children. Effect sizes were calculated to determine the magnitude of the differences. Effect size as used in these analyses was calculated by taking the differences between the groups' sample means, divided by the pooled SD. Effect sizes for differences in means are designated as small (0.20), medium (0.50), and large (0.80). 24 The overall type I error rate was maintained at 0.05 by the Hochberg adjustment for multiple comparisons. 25 An adjustment was made separately for each instrument, and separately by respondent on survey measures.
Executive functioning data were compared with the normal population by dividing it into categories based on the population mean of 50 and SD of 10, categories were >70, 61-70, 51-60, and ≤50. A c 2 goodness of fit test was used to determine if the 2 groups were different. Reported effect sizes were calculated using the Cohen W. For these data, using a nominal alpha level of 0.05 with a sample size of 14, a minimum effect size of 0.88 could be detected with 80% power.
The data from the WPPSI-IV/WISC-IV, VMI-6, and ABAS-II (mean = 100, SD = 15 for test norms), and CPT-II/K-CPT (mean = 50, SD = 10 for test norms; higher scores are worse) were compared with the normal population using c 2 and Kolmogorov-Smirnov goodness of fit tests. In the categorical comparison, a sample size of 25 and a nominal P value of .05 and 80% power an effect size of 0.66 or larger could be detected. For the continuous comparison, 1000 bootstrap simulations were performed to estimate the detectable effect size. A sample size of 25 with a nominal alpha of 0.05 and SD of 16 provided 82% power to detect a difference of 10 between the normal population mean of 100 and the sample mean. For the CPT-II/K-CPT measures, using a sample size of 19, SD 10, and nominal alpha of 0.05, 1000 simulations estimated power at 79% to detect a difference of 7 between the normal population mean of 50 and the sample mean.
The overall type I error rate was maintained at 0.05 by the Hochberg adjustment for multiple comparisons. 25 T tests were used to evaluate relationships between Motor Coordination score and baseline variables of interest and maximum HE. Pearson correlation was used to assess association between age and Motor Coordination. Previously selected key demographic and relevant medical factors were evaluated to determine relationships with parent-proxy report and self-report PedsQL MFS Cognitive Fatigue subscale scores. These associations were evaluated using a generalized linear mixed model with a random intercept to account for repeated measures of fatigue in patients. Statistical analyses were conducted using SAS v 9.4 (SAS Institute Inc, Cary, North Carolina) and SPSS v 15.0 for Windows (Microsoft Inc, Redmond, Washington). Power and effect size calculations were carried out using PASS (NCSS, LLC, Kaysville, Utah) and G*Power 3.1.7. 26 
Results
Of the 52 patients completing HRQoL surveys at 6 months, 70.2% were white, and 78.1% had parents with some college or postsecondary education. Proxy respondents included 32 mothers (78.0%), 8 fathers (19.5%), and 1 guardian (2.5%). The median age at 6 months was 7.9 years (range 3.5-15.0). The final diagnosis was indeterminate for 46.2% (n = 24). A maximal grade III or IV HE was documented in 17.3% of the sample (n = 9) during hospitalization. Medical record review indicated that 46.2% (n = 24) had received liver transplantation prior to the 6 months follow-up (n = 23 within 30 days of presentation, n = 1 at 120 days); 1 patient received liver transplantation after the 6 months follow-up visit (185 days). Table I (available at www.jpeds.com) provides descriptive statistics for participants on select demographic and medical variables.
Of the 25 patients completing the neurocognitive testing at 12 months, 56.0% (n = 14) were male, 81.8% (n = 18) were white, and 80% of parents had some college or postsecondary education. Proxy respondents included 18 mothers (72.0%) and 7 fathers (28.0%). A maximal grade III or IV HE during hospitalization was documented in 28.0% (n = 7) of the sample and 52.0% (n = 13) received liver transplantation. Twelve patients were transplanted within the first 16 days of PALF presentation, and 1 patient after the 6-month follow-up visit (185 days). Table II presents the means and SDs of the PedsQL for the study sample and the matched healthy children sample. For each scale and summary score, the study sample for both child selfreport and parent proxy-report at the 6-and 12-month visits reported significantly lower HRQoL than healthy children. Most effect sizes ranged from medium to large, with the largest found in Physical Health (1.17) and Total Score (1.10) on the child self-report. Table III presents the means and SDs of the PedsQL MFS subscales for the study sample and the sample of matched healthy children. For both child self-report and parent proxyreport at 6 and 12 months, subscale scores were significantly lower for the study group, also with medium to large effect sizes. The largest difference was noted in child self-report Total Fatigue.
HRQoL and Fatigue (Completed at 6-and 12-Month Visit)
Child Self-Report Paired Comparisons between 6 and 12 months We identified 2 key child self-report scales with large effect sizes for comparison at the 6-and 12-month follow-up. For the 21 cases in which child self-report were available at 6 and 12 months, paired t tests were conducted on the PedsQL Physical Health score and the PedsQL MFS Cognitive Fatigue subscale score. The child self-report Physical Health scores were significantly different between the 6-and 12-month followup visits with children reporting lower scores at 12 months (75.45 ± 17.99) compared with 6 months (83.78 ± 13.28) (P = .016). In addition, children reported a lower mean score on the PedsQL MFS Cognitive Fatigue subscale at 12 months (60.91 ± 22.99) compared with 6 months (73.61 ± 27.49) (P = .006). Parent proxy-report data for only the children who could self-report (n = 20) also showed a decline at 12 months (60.21 ± 25.34) compared with 6 months (71.46 ± 25.30) (P = .02). FU, follow-up interval from baseline assessment. *P ≤ .05, **P < .01, ***P < .001, based on independent samples t tests 
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Factors Associated with Cognitive Fatigue Outcome
Multivariable analysis was conducted to examine the impact of selected variables on cognitive fatigue scores by child selfreport (n = 55 observations, 34 participants) and parent proxyreport (n = 95 observations, 60 participants). Variables included age category at PALF presentation, follow-up interval from PALF presentation, parental education, liver transplantation, intubation during the PALF event, and maximal grade of HE (Tables IV and V; available at www.jpeds.com). The only significant variable in the final model was follow-up interval. Child self-report cognitive fatigue scores at 12 months were significantly lower than 6 months (P = .01). The parent-proxy report analysis included an additional 26 children less than age 5 years who did not self-report HRQoL. The same trend toward lower scores at 12 months was observed in the parent proxy-report analysis, but the difference did not reach statistical significance and no other variables emerged as significantly associated with cognitive fatigue (P = .07).
Executive Function (Completed at 6-and 12-Month Visit)
The BRIEF preschool age (n = 14) and school age (n = 17) parent report were completed at the 6-month follow-up. The distribution of BRIEF composite scores was shifted downward on the preschool age report for all indices at 6 months compared with test norms (P ≤ .003) ( Table VI) . The BRIEF preschool age (n = 10) and school age (n = 16) parent reports were also completed at the 12-month follow-up. On the preschool age reports at 12 months, participants demonstrated a higher proportion of elevated concerns on the Global Executive (P = .03) and Emergent Metacognition (P = .03) composite scales compared with test norms. There were no significant differences among distributions compared with test norms for the 6 or 12 months school age parent reports. In addition, the BRIEF self-reports at 6 (n = 13) and 12 months (n = 12) showed no significant differences compared with norms.
Neurocognitive Function (Completed at 12-Month Visit)
Table VII summarizes intelligence, visual spatial/visual motor ability, and attention scores for the 25 patients that completed neurocognitive testing at 12 months. There were no significant differences compared with norms on the WISC-IV/ WPPSI-IV, ABAS-II, or CPT-II/K-CPT. However, patients scored significantly lower than test norms on Visual Motor Integration and Motor Coordination components of the VMI-6 (P = .0002 and P = .0002, respectively). The distribution of participant scores for the Motor Coordination subscale indicates that more participants than expected had worse motor skills than in the normal population (P = .0006). There was no significant difference in the distribution of participant scores in the Visual Motor Integration subscale.
Factors Associated with Motor Coordination
Univariable analysis was performed using Motor Coordination as a continuous dependent variable and liver transplantation, highest parental education, HE at PALF presentation, and maximal grade of HE during hospitalization as the independent variables (Table VIII ; available at www.jpeds.com). None of the variables were significantly associated with Motor Coordination. The correlation of Motor Coordination with age at testing was also not significant (P = .93). Finally, the association of final diagnosis category (acetaminophen [APAP] overdose, indeterminate and other) to Motor Coordination score was not significant (P = .46).
Depression and PTSD
Thirteen participants were old enough to complete the CDI-2 and PTSD-Reaction Index. The mean score for child selfreport on the CDI-2 Total score was 53.15 ± 14.1. Of the 13 participants, 15.4% (APAP overdose n = 1, autoimmune hepatitis n = 1) had t scores ≥70, consistent with clinically significant depressive symptoms, and 38% 5 children had a score of 10 or higher on the PTSD-Reaction Index self-report. One of these also had a CDI-2 Total score ≥70, and 2 had a final diagnosis of APAP overdose.
Discussion
The present study characterized functional outcomes in children with PALF. This prospective, multicenter analysis of neurocognitive outcomes has significant implications for planning rehabilitation and setting expectations for survivors and their families. Our findings suggest that within the first year of recovery, PALF survivors may experience worse HRQoL and increased cognitive fatigue compared with healthy children. Our results also provide some evidence for a higher prevalence of Values in bold are less than P < 0.05, and thus, statistically significant. *Test norms: mean ± SD = 100 ± 15. †Test norms: mean ± SD = 50 ± 10 (higher score is worse).
motor and executive functioning deficits in PALF survivors compared with the normal population. Several small, single center studies in PALF survivors have examined cognitive function in specific disease groups including acute viral hepatitis, 4 Wilson disease, 27 and Reye syndrome, 28 but these findings are difficult to generalize to the broader group of diagnoses that lead to PALF. Srivastava et al examined 6 children with HE and cerebral edema demonstrated on advanced magnetic resonance imaging and correlated findings with serial neurocognitive testing after recovery. 4 Although scores within 3 months following PALF were significantly lower than norms, they demonstrated significant improvement at follow-up 4-7 months post event. At that point, scores were no longer significantly different from norms. We previously conducted a cross-sectional study of long-term survivors which included an array of diagnoses, but in that analysis, it was not possible to determine whether observed and reported deficits were static or improving. 7 Our results further validate findings from the previous PALFSG cross-sectional study, which found similar results in a separate sample of survivors who returned for testing up to 6 years after illness. 7 Both this current longitudinal and the previous cross-sectional study included a high proportion of liver transplantation recipients, confounding whether the findings are more representative of PALF survivors with liver transplantation than without. Multicenter analysis of liver transplantation recipients at similar survival intervals suggest liver transplantation survivors, most of whom had chronic liver disease, have more extensive neurocognitive impairment 29 including lower than expected IQ. 29 The measured and reported deficits in this PALF cohort were less severe, without any significant differences in IQ noted.
In this longitudinal study, HRQoL was significantly lower than a matched sample of healthy children. Total scores from both child and parent-reports were similar to results in longterm follow-up after liver transplantation and in children with a variety of chronic diseases. 30 Effect sizes for child selfreport scores were largest for Physical and School Function subscales on the PedsQL and for General and Cognitive Fatigue subscales on the PedsQL MFS. In a comparison of childreported Physical and Cognitive Function at 6 vs 12 months, patients reported lower function in both domains at 12 months even though there were few significant health events in patients between testing intervals. We expected HRQoL would improve at increasing interval from the PALF event as such improvement over time has been noted in both liver transplantation and critical care survivor cohorts. [31] [32] [33] However, there was a meaningful decrease in physical and cognitive function scores from both the child and parental perspectives. Child selfreport physical function scores at 12 months in this study appear lower than a previous report of recipients at 12-24 months post liver transplantation. 34 It is unclear whether patients may experience a sense of decline during the second half of the first year following the event because of expectations associated with normal daily activities, including school return to pre-event levels. We speculate that there may be rebound during the second year after liver transplantation because scores in the previous cross-sectional study more closely resembled the 6 months scores in this longitudinal study. 7 We chose to explore predictors of cognitive fatigue as function in this domain is expected to have an important impact on school reintegration and performance. Furthermore, in prior studies in pediatric liver transplantation recipients, our group has found significant correlation between cognitive fatigue scores and executive functioning (especially working memory) as tested on the BRIEF. 12 Thus, cognitive fatigue scores may reflect this dimension of cognitive function as well. The only significant predictor was follow-up interval from PALF presentation. Younger children did have lower than expected BRIEF scores, but executive functioning did not appear impaired in school age participants. HE was not a predictor of cognitive fatigue, and the only predictor of fatigue in this group was longer interval from the PALF presentation. These findings suggest PALF survivors, with or without liver transplantation, may be at risk for problems related to executive functioning (such as working memory), especially in early childhood. Given the small sample size, it is also possible the sample was not large enough to detect significant differences at the older age in this study.
One year after PALF, survivors have lower than expected motor coordination and visual motor integration. Our expectation was children with advanced HE would be at higher risk for motor impairments. Although children with a grade III or IV HE may not always demonstrate cerebral edema on imaging, 4 cerebral edema is much more common in that setting. Irreversible motor cortex injury is expected to be more likely when cerebral edema is well established, but even subclinical cerebral edema may have an impact. Univariate analysis failed to show an association between maximal level of HE and motor deficits. Because these patients did not consistently receive imaging, it was impossible to identify those with subclinical cerebral edema and thus, cerebral edema could not be assessed as a risk factor. We also considered liver transplantation as a risk factor. A recent analysis of motor function in pediatric liver transplantation recipients revealed 29% of recipients had motor impairment that did not improve over time in long-term follow-up after transplant. 35 Because one-half of our study cohort received transplantation, we tested whether these deficits were related to transplantation and found no significant association. Our inability to identify risk factors for this impairment is likely due to a lack of sensitive tools to assess cortical injury during the acute event, or small sample size.
The greatest limitation to our study is indeed small sample size, which limits power to detect small differences, and, therefore, findings must be cautiously interpreted. In part, this was due to age limits; many PALFSG patients fell below age 3 at 12 months following PALF presentation. Patients were recruited from 12 sites across the country, and there was a robust reminder system to alert coordinators of eligibility windows to maximize participation. Nevertheless, some patients who were possibly eligible for testing did not return for the 12 months clinical visit for the PALFSG. It is possible these patients were doing better and did not feel the need to return.
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Small samples are subject to bias and, in fact, a high proportion of participants lived in households with indicators of high socioeconomic status. This must be considered when generalizing findings to the broader group of children who survive PALF. In the current study, results from patients completing neurocognitive testing were variable; such may be due to small sample size and the use of various age-specific versions. Our study design emphasized rigorous neuropsychological testing. However, newer testing methods that leverage computer adapted algorithms to assess cognitive function may allow patients to report outcomes without returning to the medical center. These methods should be considered for future studies in this population.
In summary, PALF survivors have lower HRQoL than healthy children during the first year of recovery and evidence for worsening cognitive fatigue from 6 to 12 months following PALF presentation. They also appear to be at risk for executive functioning and motor deficits. Risk factors for HRQoL and neurocognitive impairments are not clear. Additional prospective studies of PALF survivors are needed to further explore predictors and longitudinal trajectories to inform clinical care, minimize modifiable risks, and support patients/families through this challenging experience. ■ Figure. One hundred fifty-eight participants were enrolled in the PALF cohort during the study period. Of 80 patients eligible to complete HRQoL surveys at 6 months, 64 attended follow-up visits and 52 completed surveys. At 12 months, 83 were eligible for HRQoL; 57 attended follow-up visits, 48 with completed surveys. At 6 months, 62 patients were in the appropriate age range to complete executive function surveys. Of 35 who attended the visit and met eligibility, 31 completed surveys. At 12 months, 59 patients were in the appropriate age range for neurocognitive testing, 28 attended the follow-up visit and were found eligible, and 25 completed test. 
